NLS Pharmaceutics
NLSP
NLSP
3 hedge funds and large institutions have $283K invested in NLS Pharmaceutics in 2021 Q1 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
3
Holders Change
+3
Holders Change %
–
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
TRCT
1
Tower Research Capital (TRC)
New York
|
$148K |
| 2 |
2
Millennium Management
New York
|
$134K |
| 3 |
CA
3
Clearstead Advisors
Cleveland,
Ohio
|
$1K |
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
TRCT
1
Tower Research Capital (TRC)
New York
| $148K | +$148K | +913 | New |
|
|
2
Millennium Management
New York
| $134K | +$134K | +830 | New |
|
|
CA
3
Clearstead Advisors
Cleveland,
Ohio
| $1K | +$1K | +8 | New |
|